Trades on 3 secondary markets

Obsidian Therapeutics

Obsidian Therapeutics is a clinical-stage biotechnology company developing engineered cell and gene therapies built on its proprietary cytoDRiVE platform, which uses drug-responsive domains to regulate therapeutic protein function with an FDA-approved small molecule. Its lead program, OBX-115, is in

minimal 13.0 / 100 0 APIs View provider profile →

Company Life Sciences Biotechnology Cell and Gene Therapy Pharmaceuticals Precision Medicine

Obsidian Therapeutics is an API provider whose private shares are listed on 3 secondary markets: Forge Global, EquityZen, Nasdaq Private Market.

Where It Trades

F Forge Global View listing → EZ EquityZen View listing → N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.